comparemela.com

Latest Breaking News On - பெஞ்சமின் பிரையண்ட் - Page 1 : comparemela.com

Veera Health raises $3mn in funding led by Surge, Global Founders Capital

Veera Health, a digital health platform for women, raised $3 million in a funding round co-led by Sequoia Capital India’s Surge and Global Founders Capital. The funding round also saw participation from Y Combinator, CloudNine Hospitals’ co-founder Rohit MA, and Tinder India Head Taru Kapoor. Angel investors, participating in the round, included Benjamin Bryant, Ethan Perlstein, Holly Liu, Utsav Somani and Walter Chen. Veera Health is also backed by global tech accelerator Y Combinator. The company’s first product is a digital therapeutics platform that helps women identify and navigate PCOS, with a comprehensive offering of medical care, nutrition therapy, lifestyle coaching and doctor support.

A Wharton MBA grad and a former GSK exec s healthcare startup raises $3 million to reach more PCOS patients

A Wharton MBA grad and a former GSK exec’s healthcare startup raises $3 million to reach more PCOS patients Sriram Iyer © Veera Health A Wharton MBA grad and a former GSK exec’s healthcare startup raises $3 million to reach more PCOS patients The Mumbai-based startup was founded in August last year. Now, the startup claims to have over 10,000 customers and has fresh funds to the tune of $3 million from marquee investors. Shashwata has an MBA from Wharton and studied data science at Yale University. Shobhita has spent several years working with leading healthcare companies including GlaxoSmithKline.In August 2020, sisters Shobhita and Shashwata Narain founded Veera Health to provide “medical care, nutrition therapy, lifestyle coaching and doctor support” for women who suffer from polycystic ovary syndrome (PCOS) ⁠ a hormonal disorder among women of reproductive age.

Oxford Instruments demonstrates capabilities of Paragraf graphene sensors

Oxford Instruments shows extended capabilities of Paragraf graphene sensors

Oxford Instruments shows extended capabilities of Paragraf graphene sensors Paragraf continues to push performance boundaries with its graphene Hall Effect sensors with Oxford Instruments employing  a modified version of the Paragraf GHS09CC sensor device to carry out measurements at temperatures and magnetic field strengths claimed to be beyond the scope of any other sensing method. The test set-up saw the modified Paragraf GHS09CC device exposed to a 14T magnetic field. This was applied via an Oxford Instruments’ superconducting solenoid magnet. The temperature level was taken down below 100mK, using the newly released Proteox dilution refrigerator. Normally under these harsh operating conditions, acquisition of field strength data would be impossible. The low temperatures involved would lead to quantum effects that would saturate the sensor. Even before reaching these extremes, other anomalies would impact upon sensor linearity, thereby making accurate measurements very diff

Oxford Instruments Demonstrate the Capabilities of Paragraf Graphene Hall Effect Sensors Under Extreme Conditions

Oxford Instruments Demonstrate the Capabilities of Paragraf Graphene Hall Effect Sensors Under Extreme Conditions Tests show accurate operation can be sustained at mK temperature levels while simultaneously exposed to ultra-strong magnetic fields. 12 May 2021, Cambridge, UK: Paragraf continues to push performance boundaries with its graphene Hall Effect sensors. Oxford Instruments, a leading provider of high technology tools and systems for research and industry, have employed a modified version of the Paragraf GHS09CC sensor device to carry out measurements at temperatures and magnetic field strengths far beyond the scope of any other sensing solution. The test set-up saw the modified Paragraf GHS09CC device exposed to a 14T magnetic field. This was applied via an Oxford Instruments’ superconducting solenoid magnet. The temperature level was taken down below 100mK, using the newly released Proteox dilution refrigerator.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.